Left atrial appendage closure for thromboembolism prevention in patients with atrial fibrillation: advances and

Bin Kong1, Yu Liu1, He Huang1

  • 11 Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China ; 2 Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China.

Journal of Thoracic Disease
|February 26, 2015
PubMed

Insights

Atrial fibrillation (AF) increases stroke risk, often due to clots in the left atrial appendage (LAA). Transcatheter LAA closure is a new method to prevent these strokes.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Interventional Cardiology

Background:

  • Atrial fibrillation (AF) is a common arrhythmia.
  • AF significantly elevates stroke risk, primarily due to thrombi formation.
  • Thrombi in non-valvular AF are predominantly located in the left atrial appendage (LAA).

Purpose of the Study:

  • To review recent advancements in transcatheter LAA closure.
  • To discuss the role of LAA closure in preventing thromboembolism for AF patients.
  • To identify potential challenges associated with LAA closure procedures.

Main Methods:

  • Literature review of transcatheter LAA closure techniques.
  • Analysis of clinical data and outcomes related to LAA closure.
  • Discussion of current challenges and future directions in LAA closure therapy.

Main Results:

  • Transcatheter LAA closure has emerged as a significant therapeutic option over the past decade.
  • This approach targets the primary source of emboli in non-valvular AF.
  • Evidence supports LAA closure as an effective stroke risk reduction strategy.

Conclusions:

  • Transcatheter LAA closure is a promising intervention for thromboembolism prevention in AF.
  • Continued research and technological advancements are crucial.
  • Addressing current challenges will optimize patient outcomes and expand therapeutic applications.